000			03651nam a22003975i 4500
988			_aSpringer_Medicine_2016
999			_c84659 _d84659 _x1
001			84659
003			ES-MaUEC
005			20230207040434.0
007			cr nn 008mamaa
008			150717s2016 gw | s |||| 0|eng d
020			_a9783319197258
040			_aES-MaUEC
050		4	_aK3611.G46 _b2016 EB
082	0	4	_a610.1
082	0	4	_a174.2
100	1		_aChennells, Roger _997006 _0Local
245	1	0	_aEquitable Access to Human Biological Resources in Developing Countries : _bBenefit Sharing Without Undue Inducement _cby Roger Scarlin Chennells
260			_aCham _bSpringer International Publishing _c2016
300			_a1 recurso en línea (XIX, 197 páginas) :
336			_aTexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
505	0		_aIntroduction -- Exploitation -- Common Heritage of Humankind -- The Altruism Argument -- The �No Value Added� Argument -- Justice and Exploitation in Bilateral Exchanges -- Undue Inducement and Coercion -- Risks to Indigenous Peoples as Vulnerable Population -- Closing Chapter.
520	3		_aThe main question explored by the book is: How can cross-border access to human genetic resources, such as blood or DNA samples, be governed in such a way as to achieve equity for vulnerable populations in developing countries?� The book situates the field of genomic and genetic research within global health and research frameworks, describing the concerns that have been raised about the potential unfairness in exchanges during recent decades. Access to and sharing in the benefits of human biological resources are aspects not regulated by any international legal framework such as the Convention on Biological Diversity, which applies only to the exchange of plants, animals and microorganisms, as well as to associated traditional knowledge. Examples of genetic research perceived as exploitative are provided in order to illustrate the legal vacuum concerning the global governance of human genetic resources. The main conclusions drawn from the legal and ethical analysis are: � Benefit sharing is crucial in order to avoid the exploitation of developing countries in human genetic research. � With functioning research ethics committees, undue inducement is less of a concern in genetic research than in other areas of medical research (e.g. clinical trials). � Concerns remain over research involving indigenous populations; accordingly, recommendations are provided. In drawing these conclusions, the book addresses in detail a highly pressing topic in global bioethics and international law. In this regard, it combines bioethical arguments with jurisprudence, in particular with reference to the law of equity and the legal concepts of duress (coercion), unconscionable dealing, and undue inducement.
650		7	_aMedicina _0comprobar BNE19900959047 _2embne _9405021
650		7	_aÉtica médica _0comprobar BNE20010094441 _2embne _9158065
651		7	_aDeveloping countries _0(OCoLC)1242969 _2fast _9665312 _0LocalX
710	2		_aSpringerLink (Online service) _0Local _9106996
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-19725-8 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
901			_ai9783319197258
907			_a.b12939377 _b10-10-17 _c21-11-16
942			_2lcc _cLE
945			_aK3611.G46 C446 2016 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11583861 _z06-04-17
998			_am _a_alco _a_vill _b - - _cm _dz _e- _feng _ggw _h0